Detalhe da pesquisa
1.
Screening of Fabry disease in patients with chronic kidney disease in Japan.
Nephrol Dial Transplant
; 37(1): 115-125, 2021 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282462
2.
The study investigating the determination of protamine in seminal plasma from azoospermic donors: Suggestion of new methods to diagnose obstructive azoospermia, and to capture childbearing sperm for testicular sperm extraction (TESE) and insemination sperm injection (ICSI).
Anal Biochem
; 604: 113792, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622977
3.
Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review.
BMC Nephrol
; 20(1): 469, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847900
4.
Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy.
Clin Exp Nephrol
; 22(4): 843-849, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288396
5.
Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy.
Mol Genet Metab
; 120(1-2): 116-120, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756537
6.
Erratum to: Screening of Fabry disease in patients with chronic kidney disease in Japan.
Nephrol Dial Transplant
; 36(11): 2155-2159, 2021 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535801
7.
A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.
Clin Nephrol
; 83(5): 301-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25295576
8.
Comparative study on mannose 6-phosphate residue contents of recombinant lysosomal enzymes.
Mol Genet Metab
; 111(3): 369-373, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24439675
9.
A case of Fabry nephropathy with histological features of oligonephropathy.
Eur J Pediatr
; 173(8): 1111-4, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913314
10.
Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?
Mol Genet Metab Rep
; 39: 101079, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38601121
11.
The stable o-phthalaldehyde-ferrocene/6-ferrocenyl-1-hexanethiol pre-column derivatization high-performance liquid chromatography of dimethylarginine by novel dual fluorescence and electrochemical detector.
Biomed Chromatogr
; 27(4): 535-8, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23018892
12.
Application of the relative molar sensitivity method using GC-FID to quantify safranal in saffron (Crocus sativus L.).
J Nat Med
; 77(4): 829-838, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450205
13.
Monitoring of anti-drug antibodies and disease-specific biomarkers in three patients from a Japanese Fabry family treated with enzyme replacement therapy.
CEN Case Rep
; 12(2): 171-175, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36205882
14.
Profiles of Globotriaosylsphingosine Analogs and Globotriaosylceramide Isoforms Accumulated in Body Fluids from Various Phenotypic Fabry Patients.
Intern Med
; 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866916
15.
In Vivo Delivery of Therapeutic Molecules by Transplantation of Genome-Edited Induced Pluripotent Stem Cells.
Cell Transplant
; 32: 9636897231173734, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183961
16.
Effects of switching from agalsidase-α to agalsidase-ß on biomarkers, renal and cardiac parameters, and disease severity in fabry disease forming neutralizing antidrug antibodies: a case report.
CEN Case Rep
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135868
17.
Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease.
Am J Hum Genet
; 85(5): 569-80, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19853240
18.
Efficient uptake of recombinant α-galactosidase A produced with a gene-manipulated yeast by Fabry mice kidneys.
Mol Med
; 18: 76-82, 2012 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22033676
19.
Fabry disease: biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution.
Mol Genet Metab
; 105(4): 615-20, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22305854
20.
Mutant α-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level.
Mol Genet Metab
; 107(3): 623-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22841442